Xenon as a Potential Enhancer of Hypoxic Adaptation Rather Than Its Substitute: A Narrative Review
DOI:
https://doi.org/10.12775/QS.2026.55.71280Keywords
xenon, hypoxia, HIF-1α, erythropoietin, acclimatizationAbstract
Background. Xenon has been proposed as a potential agent influencing erythropoiesis through activation of hypoxia-inducible pathways. However, its role in high-altitude physiology and hypoxic adaptation remains unclear and controversial. Aim. This study aimed to evaluate whether xenon may act as a modulator of hypoxic adaptation rather than a substitute for hypoxic exposure. Material and methods. This study is a narrative literature review based on scientific publications indexed in the PubMed database between 1998 and 2025. The literature search included keywords such as xenon, hypoxia, HIF-1α, erythropoietin, hypoxic adaptation, and acclimatization. Original studies, review articles, and experimental studies investigating the physiological and molecular effects of xenon were included. Studies not related to hypoxia or adaptive physiological responses were excluded. Results. Available evidence indicates that xenon transiently increases erythropoietin levels via activation of the HIF pathway; however, these effects do not translate into sustained physiological adaptations such as increased hemoglobin mass or improved aerobic performance. Notably, most studies have evaluated xenon in isolation, without integration into complex adaptive conditions such as combined hypoxia and physical training. Conclusions. Xenon does not appear to substitute for hypoxic adaptation. Its potential role as a modulator of hypoxia-induced physiological responses remains insufficiently explored and requires further investigation within integrated experimental models.References
Ainslie PN, Lucas SJE, Burgess KR. Breathing and sleep at high altitude. Respir Physiol Neurobiol. 2013;188(3):233–256. https://doi.org/10.1016/j.resp.2013.05.020
Ainslie PN, Subudhi AW. Cerebral blood flow at high altitude. High Alt Med Biol. 2014;15(2):133–140. https://doi.org/10.1089/ham.2013.1138
Berger MM, Luks AM. High altitude. Semin Respir Crit Care Med. 2023;44(5):681–695. https://doi.org/10.1055/s-0043-1770063
Gatterer H, Villafuerte FC, Ulrich S, Bhandari SS, Keyes LE, Burtscher M. Altitude illnesses. Nat Rev Dis Primers. 2024;10(1):43. https://doi.org/10.1038/s41572-024-00526-w
Luks AM, Beidleman BA, Freer L, Grissom CK, Keyes LE, McIntosh SE, Rodway GW, Schoene RB, Zafren K, Hackett PH. Wilderness Medical Society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2024 update. Wilderness Environ Med. 2024;35(S1):2S–19S. https://doi.org/10.1016/j.wem.2023.05.013
Mallet RT, Burtscher J, Pialoux V, Pasha Q, Ahmad Y, Millet GP, Burtscher M. Molecular mechanisms of high-altitude acclimatization. Int J Mol Sci. 2023;24(2):1698. https://doi.org/10.3390/ijms24021698
Xie J, Xie S, Zhong Z, Dong H, Huang P, Zhou S, Tian H, Zhang J, Wu Y, Li P. Hypoxic preacclimatization combining intermittent hypoxia exposure with physical exercise significantly promotes tolerance to acute hypoxia. Front Physiol. 2024;15:1367642. https://doi.org/10.3389/fphys.2024.1367642
Hilty MP, Hefti U, Bouzat P, Gatterer H, Horakova L, Keyes LE, Lawley J, Levine BD, Rodway G, Trevena D, Vinhaes E, Champigneulle B. Xenon inhalation for expeditions to high altitude: A position statement from the UIAA Medical Commission. High Alt Med Biol. 2025;26(4):385–387. https://doi.org/10.1089/ham.2025.0018
Jin Z, Piazza O, Ma D, Scarpati G, De Robertis E. Xenon anesthesia and beyond: Pros and cons. Minerva Anestesiol. 2019;85(1):83–89. https://doi.org/10.23736/S0375-9393.18.12909-9
Liang M, Ahmad F, Dickinson R. Neuroprotection by the noble gases argon and xenon as treatments for acquired brain injury: A preclinical systematic review and meta-analysis. Br J Anaesth. 2022;129(2):200–218. https://doi.org/10.1016/j.bja.2022.04.016
Zhou Z, Sun F, Jiang B. Research progress in the role of hypoxia-inducible factor 1 in altitude sickness and underlying mechanisms. Sichuan Univ Med J. 2024;55(6):1424–1435. https://doi.org/10.12182/20241160303
Robach P, Calbet JAL, Thomsen JJ, Boushel R, Mollard P, Rasmussen P, Lundby C. The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS One. 2008;3(8):e2996. https://doi.org/10.1371/journal.pone.0002996
Pandolf KB, Young AJ, Sawka MN, Kenney JL, Sharp MW, Cote RR, Freund BJ, Valeri CR. Does erythrocyte infusion improve 3.2-km run performance at high altitude? Eur J Appl Physiol. 1998;79(1):1–6. https://doi.org/10.1007/s004210050465
Siebenmann C, Cathomen A, Hug M, Keiser S, Lundby AK, Hilty MP, Goetze JP, Rasmussen P, Lundby C. Hemoglobin mass and intravascular volume kinetics during and after altitude exposure. J Appl Physiol. 2015;119(10):1194–1201. https://doi.org/10.1152/japplphysiol.01121.2014
Dias KA, Lawley JS, Gatterer H, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Liang AS-W, Hendrix M, Piper T, Thevis M, Bruick RK, Levine BD. Effect of acute and chronic xenon inhalation on erythropoietin, hematological parameters, and athletic performance. J Appl Physiol. 2019;127(6):1503–1510. https://doi.org/10.1152/japplphysiol.00289.2019
Lawley JS, Gatterer H, Dias KA, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Bruick RK, Hendrix M, Piper T, Thevis M, Levine BD. Safety, hemodynamic effects, and detection of acute xenon inhalation: Rationale for banning xenon from sport. J Appl Physiol. 2019;127(6):1511–1518. https://doi.org/10.1152/japplphysiol.00290.2019
Stoppe C, Coburn M, Fahlenkamp A, Ney J, Kraemer S, Rossaint R, Goetzenich A. Elevated serum concentrations of erythropoietin after xenon anaesthesia in cardiac surgery. Br J Anaesth. 2015;114(4):701–703. https://doi.org/10.1093/bja/aev060
Stoppe C, Ney J, Brenke M, Goetzenich A, Emontzpohl C, Schälte G, Grottke O, Moeller M, Rossaint R, Coburn M. Sub-anesthetic xenon increases erythropoietin levels in humans: A randomized controlled trial. Sports Med. 2016;46(11):1753–1766. https://doi.org/10.1007/s40279-016-0505-1
Hilty MP, Merz TM, Hefti U, Ince C, Maggiorini M, Hefti JP. Recruitment of non-perfused sublingual capillaries increases microcirculatory oxygen extraction capacity throughout ascent to 7126 m. J Physiol. 2019;597(10):2623–2638. https://doi.org/10.1113/jp277590
Fedorova EP, Filonova MV, Churin AA, Naumov SA, Nikiforov PE, Sandrikina LA, Evtushenko DN, Udut EV, Popov OS, Naumov SS, Fomina TI, Udut VV. Xenon-induced effects in relieving experimental acute respiratory distress syndrome. Bull Exp Biol Med. 2023;174(5):605–609. https://doi.org/10.1007/s10517-023-05755-9
Manferdelli G, Berger MM, Luks AM. Ignoble Gas: The Questionable Role of Xenon in Rapid Ascents of Mount Everest. High Alt Med Biol. 2025;26(4):339–346. https://doi.org/10.1177/15578682251377419
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Michał Tryba, Anna Paluch, Gabriela Grylowska, Katarzyna Gunia, Aleksandra Adamczyk, Mateusz Banasik, Marcin Rebizant, Agata Żak, Andrzej Palak, Anna Ignatowicz

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 24
Number of citations: 0